Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22035,170,1.16 [0.90-1.49],0.2519433156882978
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23036,182,1.08 [0.85-1.39],0.518999362642705
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22787,1367,1.20 [1.10-1.31],7.180058652866588e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23046,364,1.25 [1.06-1.48],0.0074691109517012
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22368,3368,1.13 [1.07-1.20],1.916633529230548e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22344,3408,1.25 [1.18-1.32],2.6906652925426948e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22843,1016,1.10 [0.99-1.22],0.0754347768370756
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22974,78,1.17 [0.81-1.69],0.3895801655219397
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20873,1082,1.15 [1.04-1.27],0.0063851960506814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20157,1208,1.20 [1.09-1.32],0.0001897704506736
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19873,242,1.25 [1.02-1.53],0.0328259706076995
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16227,2212,1.27 [1.18-1.36],1.20882951131168e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19804,390,1.34 [1.14-1.58],0.0004635607134484
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23037,1210,1.12 [1.02-1.24],0.0162791546507763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,23131,449,1.18 [1.02-1.38],0.0298813635872284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22289,869,1.23 [1.10-1.37],0.0002978236110787
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23058,1193,1.14 [1.04-1.25],0.0073099978895844
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22010,183,1.08 [0.85-1.38],0.5271553736383892
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23170,52,0.82 [0.50-1.34],0.4224615315528244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22908,1043,1.13 [1.02-1.25],0.0173918614698356
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22962,66,1.01 [0.67-1.53],0.9613982317010248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23111,114,1.14 [0.83-1.57],0.4151679054384078
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23093,96,1.11 [0.78-1.58],0.5657919345697222
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21894,474,1.19 [1.02-1.38],0.0268503826215424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21694,274,1.13 [0.93-1.39],0.2244726199717692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21911,84,1.44 [1.03-2.02],0.0350083813265081
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23151,66,1.01 [0.67-1.53],0.9519305841460644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23116,139,1.33 [1.02-1.75],0.0384090614055872
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral warts,23028,51,1.18 [0.74-1.89],0.4813204370110268
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23025,48,1.25 [0.78-2.00],0.3438626421173935
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,22864,334,0.98 [0.81-1.18],0.815916376374733
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23100,44,0.81 [0.47-1.39],0.436198395649459
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23067,52,0.79 [0.48-1.31],0.3587855146868244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23124,127,1.00 [0.73-1.36],0.9810586207199424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22805,1595,1.08 [0.99-1.17],0.0873288698256823
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of meninges,23171,33,0.95 [0.52-1.75],0.8665189099329688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23109,63,1.01 [0.66-1.53],0.9808088778264814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23154,70,1.73 [1.21-2.48],0.0026565564328227
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23145,427,1.02 [0.86-1.20],0.8491394876518745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Caecum,23141,339,0.92 [0.76-1.11],0.3575629915318028
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23043,79,1.03 [0.70-1.50],0.8899573771239256
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23137,267,1.14 [0.94-1.39],0.1923429849738947
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,23100,403,1.15 [0.98-1.36],0.0899547329544871
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23050,706,1.12 [0.99-1.27],0.0753599838179994
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23127,542,1.10 [0.95-1.27],0.197049266028541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18014,68,1.28 [0.86-1.90],0.2247594027180996
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18013,67,1.05 [0.69-1.60],0.8086234447367193
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23140,95,0.87 [0.60-1.25],0.4477388856649702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",23140,92,0.93 [0.64-1.34],0.6870049360668573
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lung cancer and mesothelioma,15439,337,1.92 [1.66-2.23],4.52585559479409e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lymphoid leukaemia,18008,62,1.33 [0.88-2.02],0.1711719721160933
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18138,192,1.10 [0.86-1.42],0.4332107796878401
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18230,284,1.02 [0.84-1.24],0.84532902760608
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18032,86,1.04 [0.73-1.47],0.8358518278813624
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18082,136,1.21 [0.92-1.60],0.1694132526277431
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18081,135,1.08 [0.82-1.42],0.595291431783463
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18024,78,0.92 [0.62-1.35],0.6541286023103616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19303,1357,1.02 [0.93-1.12],0.7309044743666633
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18086,140,1.17 [0.89-1.54],0.2645473695934909
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18046,100,1.02 [0.74-1.42],0.9019613386792446
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18072,126,1.02 [0.75-1.39],0.8819551655527351
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,23046,166,1.09 [0.83-1.42],0.5391608092931615
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of trunk,23139,91,1.00 [0.70-1.45],0.9872444609822072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanoma in situ,17977,71,0.99 [0.65-1.50],0.9583589254558408
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18043,97,1.11 [0.78-1.56],0.5609026690024632
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18107,161,1.16 [0.89-1.51],0.2785450668307028
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18160,214,1.59 [1.32-1.91],9.70275849633866e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18045,99,1.29 [0.93-1.79],0.1290964176143954
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,23038,130,1.19 [0.89-1.60],0.232777562173949
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19114,1168,1.01 [0.91-1.12],0.8249554831582053
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19188,1242,1.02 [0.92-1.12],0.7426410863030608
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22913,299,1.10 [0.91-1.34],0.3139364820261279
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21478,113,1.05 [0.77-1.43],0.7729661043464713
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22680,66,1.16 [0.77-1.75],0.4844486869195737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22628,2704,1.08 [1.02-1.16],0.0155371333425648
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21927,60,1.39 [0.93-2.07],0.1057813135687595
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22753,52,1.33 [0.86-2.07],0.2015524617878777
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22800,1435,1.10 [1.01-1.20],0.0282015686017031
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22799,1434,1.09 [1.00-1.20],0.0435289400385737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21465,100,1.06 [0.76-1.48],0.7286467415257434
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22937,1070,1.13 [1.02-1.25],0.0213722407745441
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22804,103,1.45 [1.06-1.98],0.0196527245955582
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22686,72,1.06 [0.73-1.56],0.7502043594302181
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22673,59,1.32 [0.86-2.01],0.2017357612732948
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23011,310,1.36 [1.14-1.63],0.0006604038920209
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23079,47,1.35 [0.84-2.17],0.2145727687213579
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22954,253,1.35 [1.11-1.65],0.0031586421626939
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21941,74,1.11 [0.75-1.64],0.6095824344553346
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17090,368,1.37 [1.16-1.62],0.0002173129779978
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21186,158,1.01 [0.79-1.30],0.9090118787685788
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21208,180,1.13 [0.90-1.41],0.2860054634961547
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,16777,55,1.73 [1.17-2.58],0.0064747489859056
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21840,64,1.18 [0.80-1.75],0.3972778713647743
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21088,216,1.44 [1.16-1.78],0.0008429454584346
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22676,605,1.13 [0.99-1.30],0.0637006305861218
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22308,237,0.85 [0.67-1.07],0.1566433623650301
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22239,168,0.91 [0.70-1.20],0.5163406905475918
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22876,1100,1.05 [0.95-1.16],0.3096249232023386
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19810,1056,1.11 [1.00-1.23],0.0446120139358936
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",16794,72,1.11 [0.74-1.65],0.6201546355769112
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22311,37,1.18 [0.69-2.04],0.5437237628205638
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,16987,265,1.30 [1.06-1.58],0.0099286162418784
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,16791,69,1.20 [0.80-1.80],0.3890901308242397
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20489,3767,1.09 [1.03-1.15],0.00311475933167
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,16899,177,1.16 [0.90-1.48],0.2514870528522822
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17270,548,1.20 [1.04-1.38],0.0108714898824067
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23113,267,1.48 [1.22-1.80],6.36477187689729e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22930,84,1.56 [1.11-2.18],0.0097314548667187
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,16870,148,1.12 [0.85-1.48],0.4078535144314483
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",16784,62,1.12 [0.72-1.73],0.6235340140191094
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22995,721,1.22 [1.08-1.38],0.001435048275213
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17022,300,1.70 [1.43-2.02],2.084881119549005e-09
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17089,367,1.46 [1.24-1.72],7.602996391516259e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17428,706,1.17 [1.03-1.33],0.0132465902659965
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,16864,142,0.85 [0.63-1.15],0.2942871909195063
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22924,78,1.55 [1.09-2.20],0.0137353513983676
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17279,557,1.18 [1.02-1.35],0.023410858185472
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17103,381,1.22 [1.03-1.44],0.0202761846698901
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20940,68,1.42 [0.97-2.10],0.0742505368513342
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21762,5040,1.12 [1.07-1.17],5.044384820197398e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22294,20,3.46 [2.01-5.98],8.187406698305018e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22295,21,0.90 [0.43-1.91],0.7927298474942766
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23001,1722,1.05 [0.97-1.14],0.2441925413704127
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22998,1718,1.05 [0.97-1.14],0.2542644588818325
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22295,21,1.44 [0.75-2.76],0.2686653764305188
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22908,779,1.16 [1.03-1.31],0.0120425086809991
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18299,1577,1.26 [1.16-1.36],4.13141109717411e-08
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23159,262,1.22 [1.00-1.49],0.0465218469338593
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22178,107,1.49 [1.11-2.00],0.0087514536114334
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22202,73,1.19 [0.82-1.73],0.3492155335973486
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22210,81,0.88 [0.59-1.29],0.5031932243960286
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",16787,65,1.00 [0.64-1.56],0.9897431974559096
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20467,160,1.13 [0.87-1.47],0.3540590736511382
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2421,119,1.32 [0.99-1.77],0.0568832634176261
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2579,308,0.87 [0.72-1.06],0.1813331282052901
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20402,95,0.96 [0.69-1.34],0.7985487504808599
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2379,79,1.23 [0.86-1.76],0.2580021246707505
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22405,2098,1.00 [0.93-1.07],0.925106153202336
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22427,356,1.14 [0.96-1.36],0.140109559235652
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21108,236,1.36 [1.11-1.67],0.003490767338258
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17499,777,1.28 [1.14-1.44],2.5449859548198137e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23048,246,1.11 [0.90-1.38],0.3199171458048404
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21983,270,1.53 [1.28-1.83],2.1457410589911862e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,20318,1461,1.12 [1.03-1.23],0.0088278406813725
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22088,375,1.30 [1.11-1.53],0.0011308735476421
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21796,83,1.73 [1.27-2.33],0.0004094207308452
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21955,242,1.76 [1.47-2.10],7.459932874056004e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13569,2245,1.17 [1.09-1.26],7.499690621778509e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,AV-block,18637,599,1.09 [0.94-1.25],0.254828957871819
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23097,523,1.01 [0.87-1.17],0.9052514805638304
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,11575,251,1.39 [1.14-1.69],0.0011916111675734
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18235,197,1.27 [1.01-1.61],0.0437833427540983
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18146,108,0.96 [0.69-1.34],0.8161976024344466
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23172,66,1.60 [1.11-2.31],0.0126719325762045
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,19352,1314,1.13 [1.03-1.24],0.0093946832514195
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21399,2565,1.19 [1.12-1.27],1.224878076486652e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19502,7526,1.03 [0.99-1.07],0.1262361124426924
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21984,270,1.11 [0.91-1.36],0.3013545869070538
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Endocarditis,18119,81,1.42 [0.99-2.05],0.0568244460753702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22867,1290,1.34 [1.23-1.46],5.4430296157716675e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,20666,6561,1.03 [0.99-1.08],0.1270291233741209
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20688,6583,1.03 [0.99-1.07],0.1955398540986667
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22952,103,1.08 [0.78-1.49],0.6541134518707206
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14282,177,2.28 [1.88-2.78],1.3570054756352168e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14270,165,1.61 [1.28-2.01],3.5092742658498536e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,23025,1202,1.30 [1.19-1.43],1.032462624000202e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22127,116,1.16 [0.85-1.57],0.3520315217479218
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21536,2679,1.15 [1.08-1.23],1.9398678416042103e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22749,632,1.30 [1.15-1.47],4.462330319692444e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18443,405,1.24 [1.05-1.46],0.01158044998175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22460,1037,1.28 [1.16-1.41],1.0101432675890964e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19756,899,1.31 [1.18-1.46],4.865304381127867e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23015,212,1.38 [1.12-1.71],0.0024093213963127
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23119,367,1.20 [1.01-1.43],0.034926018945134
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21779,65,1.05 [0.69-1.58],0.8274695107031571
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other aneurysm,21808,95,1.08 [0.77-1.50],0.663113225333692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,18505,467,1.13 [0.97-1.33],0.1234469009031521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21847,134,1.58 [1.24-2.01],0.0002344010217842
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21982,269,1.43 [1.19-1.72],0.0001138064881626
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18228,190,1.49 [1.18-1.88],0.0007317442956399
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,21811,97,1.24 [0.90-1.72],0.1880568059442084
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21762,48,0.96 [0.60-1.53],0.8555168801225279
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21621,84,1.28 [0.89-1.83],0.1781086214634616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21818,104,0.99 [0.71-1.37],0.9320849927132402
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19250,1212,1.32 [1.20-1.45],1.1621079847926956e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21886,63,1.04 [0.69-1.57],0.8560694089609651
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22274,561,1.55 [1.37-1.75],4.206436955039841e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22538,351,2.15 [1.86-2.48],1.4823799376644459e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22184,647,1.21 [1.07-1.37],0.0033267826413209
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11695,371,1.22 [1.03-1.44],0.0243006768273361
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22183,515,1.53 [1.35-1.74],6.494776049140423e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22064,350,1.18 [0.99-1.41],0.0667180332909112
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22676,489,1.21 [1.04-1.40],0.0130081304036521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23108,690,1.32 [1.17-1.50],7.142306247819285e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18495,457,1.21 [1.04-1.42],0.0156205356752237
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22536,349,2.14 [1.86-2.48],2.2301812964567402e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21755,218,1.37 [1.11-1.69],0.0028183608999454
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22733,722,1.28 [1.14-1.44],3.347406933891507e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22718,750,1.26 [1.12-1.41],0.0001189466999739
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22108,46,0.95 [0.57-1.58],0.844766684881733
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21823,111,1.12 [0.82-1.55],0.4716485405979553
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22360,243,1.03 [0.82-1.28],0.8248552601440218
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21728,305,1.29 [1.07-1.55],0.0071570381311597
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,22081,367,1.09 [0.91-1.30],0.3517595109692053
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21731,73,1.48 [1.03-2.12],0.0347617729239122
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22936,767,1.16 [1.03-1.30],0.0176046004247312
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22978,482,0.98 [0.85-1.14],0.8293763046952961
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19913,943,1.24 [1.12-1.38],4.81026035811164e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,22506,3536,1.19 [1.13-1.25],1.1140005412406847e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22918,569,1.02 [0.89-1.16],0.7996928879245511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20105,1135,1.12 [1.02-1.24],0.0233544787490612
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19054,84,0.92 [0.64-1.34],0.672516386818896
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,22541,1490,1.37 [1.28-1.47],1.1128398814905961e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20784,1814,1.30 [1.23-1.38],4.1571608267613784e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Vascular dementia,22668,150,1.38 [1.07-1.79],0.0125419456052421
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Alzheimer disease,23170,291,0.92 [0.75-1.12],0.3938930378835715
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15404,57,1.14 [0.74-1.77],0.5452589348312527
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Bell's palsy,21849,71,1.10 [0.73-1.65],0.6629222206770485
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22104,326,0.98 [0.81-1.18],0.7967159288159913
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral cysts,22781,231,1.07 [0.86-1.33],0.5517878535883687
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23087,354,1.15 [0.97-1.37],0.1015713269362225
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22672,57,0.92 [0.58-1.46],0.7276582687213022
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23153,74,0.96 [0.64-1.44],0.8490983976526472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22639,89,1.00 [0.70-1.44],0.9949368284688476
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,21601,274,0.99 [0.80-1.21],0.912702153813118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22645,1318,1.05 [0.95-1.15],0.3504736149517292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23134,675,0.90 [0.78-1.03],0.1270407907471817
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22642,2163,1.08 [1.01-1.16],0.030282332970317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,22800,58,1.14 [0.74-1.75],0.5652174841400326
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,23004,271,1.28 [1.06-1.55],0.0109135839186121
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hydrocephalus,22605,55,1.27 [0.82-1.96],0.2823181465203302
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23152,54,1.38 [0.89-2.12],0.1468569485099967
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21799,21,0.56 [0.24-1.29],0.1707432651265982
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21866,88,1.44 [1.04-2.01],0.0294994724398548
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Memory loss,22510,118,0.98 [0.71-1.35],0.8954171329778551
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,21522,195,1.09 [0.85-1.41],0.4775919320698755
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23146,176,1.11 [0.85-1.44],0.4400216620546674
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Motor neuron disease,15504,145,1.00 [0.75-1.33],0.9896800579873476
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23062,60,0.97 [0.63-1.49],0.8871766444860737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22710,932,0.98 [0.88-1.10],0.7240493367736048
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,21891,3560,1.02 [0.97-1.09],0.4092702693933532
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22852,237,0.90 [0.72-1.12],0.3481884584079473
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22159,381,0.90 [0.75-1.07],0.2367390931897812
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23078,342,1.30 [1.09-1.54],0.0032724714266914
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18180,606,0.95 [0.83-1.10],0.5197358084369765
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22625,75,1.04 [0.70-1.54],0.8387327617610886
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22701,151,0.84 [0.63-1.12],0.2237319984801076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22598,139,1.26 [0.95-1.66],0.1035852566971396
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21866,88,0.99 [0.68-1.43],0.9522910013197377
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other headache syndromes,21362,35,0.83 [0.45-1.54],0.5610059445935163
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,23059,509,1.06 [0.91-1.23],0.4769131208769641
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,22007,680,1.07 [0.94-1.22],0.3249518650254296
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Parkinson's disease,23148,528,0.89 [0.77-1.04],0.1597776665822218
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22576,26,0.91 [0.45-1.83],0.7820659989916243
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23170,51,1.40 [0.90-2.17],0.1317760574370132
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,22872,613,1.07 [0.93-1.22],0.3612918517938454
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22789,53,1.22 [0.77-1.94],0.3922354658952586
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23155,169,0.99 [0.76-1.28],0.9268021490580408
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21810,32,0.85 [0.46-1.58],0.6052481267022112
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23170,294,0.91 [0.75-1.12],0.3814970203524583
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22640,146,1.40 [1.08-1.81],0.0102275222747102
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22636,85,1.21 [0.86-1.71],0.2682652821027118
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22837,294,1.17 [0.96-1.43],0.1220123111588456
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22973,285,0.81 [0.66-1.00],0.0477560077696241
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22322,42,1.41 [0.87-2.30],0.1672829543052484
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22340,60,1.13 [0.73-1.73],0.5913867614996415
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23079,41,0.72 [0.41-1.27],0.2567704973870247
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22943,123,1.18 [0.87-1.59],0.2976963635451141
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2383,81,1.31 [0.92-1.86],0.132827875422546
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2910,127,1.34 [1.01-1.77],0.0414653378626559
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22642,91,1.40 [1.00-1.96],0.047095076246054
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22927,970,0.86 [0.77-0.96],0.0096073409423352
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22873,593,1.13 [0.99-1.30],0.0720183426995156
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22424,144,1.17 [0.88-1.55],0.2694285686522657
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23098,555,1.06 [0.92-1.23],0.4029063515529034
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23167,64,1.11 [0.73-1.70],0.6227519611023852
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23031,488,1.08 [0.92-1.26],0.3587682024761662
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23131,311,1.00 [0.82-1.21],0.9679954457276728
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23083,148,0.70 [0.52-0.96],0.0250138467752683
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22354,74,1.04 [0.71-1.54],0.8275943816436975
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22361,81,0.95 [0.65-1.38],0.7873618126943462
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22324,44,1.22 [0.74-2.02],0.4432996188618047
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23080,659,0.92 [0.81-1.06],0.2553053568878846
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22598,177,0.91 [0.69-1.19],0.4750214737439696
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22572,29,0.94 [0.48-1.82],0.8512377300159192
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22912,92,0.81 [0.55-1.17],0.2579574756130852
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23045,225,1.09 [0.87-1.37],0.4609466414500947
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22707,164,0.97 [0.74-1.28],0.8232530421498776
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23019,84,0.58 [0.38-0.89],0.0128832948029115
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22868,447,0.98 [0.83-1.15],0.762555003980178
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22675,124,0.89 [0.65-1.21],0.4481556003353297
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21824,1729,0.99 [0.91-1.07],0.7626208929152761
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23014,194,1.02 [0.79-1.31],0.8726995354359445
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23156,144,0.93 [0.69-1.24],0.6062032708391969
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22680,400,1.09 [0.92-1.28],0.3271762182088221
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22882,62,1.08 [0.71-1.66],0.7150342967641125
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23158,55,1.07 [0.68-1.69],0.774988891479716
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22350,70,1.34 [0.91-1.97],0.1377545058953117
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22416,136,1.31 [0.99-1.72],0.057466580107731
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22083,126,0.88 [0.64-1.21],0.4405075798407889
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22592,49,1.03 [0.63-1.68],0.9057959480652192
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22019,62,0.89 [0.56-1.41],0.6207120006566988
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22472,51,1.33 [0.85-2.10],0.2093783552649628
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22620,199,0.94 [0.73-1.20],0.6186012047578184
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22392,112,1.23 [0.91-1.68],0.1818411923784443
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22073,116,0.76 [0.54-1.08],0.1231184681571176
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22045,88,1.07 [0.75-1.54],0.6966746286988111
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21531,1436,1.09 [1.00-1.19],0.0537253219113182
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22337,57,1.14 [0.73-1.78],0.5617252841528895
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22930,379,1.15 [0.97-1.36],0.114143623040022
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22619,68,1.18 [0.80-1.73],0.4073029640726145
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22716,165,1.10 [0.85-1.42],0.4539413050525847
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22997,57,0.81 [0.50-1.33],0.4074699138377521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23127,118,0.83 [0.60-1.14],0.2501165781816936
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23040,105,0.88 [0.62-1.23],0.4471934299507325
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22988,48,1.87 [1.22-2.88],0.0043800206913248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22991,51,1.47 [0.95-2.28],0.0850222038260333
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23075,929,0.98 [0.88-1.10],0.7661594507409116
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22836,690,0.99 [0.87-1.13],0.9095965940443864
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22267,121,0.59 [0.42-0.84],0.0028857385477918
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22228,82,1.22 [0.85-1.76],0.2821799975963832
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,22962,60,1.15 [0.75-1.75],0.527268772307385
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23087,185,0.91 [0.70-1.17],0.4575070984843996
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22962,60,0.96 [0.61-1.50],0.8510629983639251
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza,20950,103,1.47 [1.08-1.99],0.0133639313180545
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20947,100,1.41 [1.03-1.92],0.0323588626565126
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15203,101,1.16 [0.81-1.66],0.4174604499740264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23064,257,0.77 [0.61-0.96],0.0230026299344577
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16152,1386,1.17 [1.07-1.29],0.0010289379177244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16463,1361,1.17 [1.06-1.28],0.0015682685657793
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22800,147,1.09 [0.83-1.42],0.5378704351915771
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20941,94,1.22 [0.88-1.68],0.2343449297224309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bronchiectasis,20160,281,1.68 [1.41-2.00],9.459546406474329e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19921,42,1.64 [1.06-2.54],0.0258844168486032
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22353,2474,1.31 [1.23-1.40],1.6722141842204892e-17
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21765,75,0.62 [0.41-0.96],0.0326930918698214
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,21846,156,0.84 [0.63-1.11],0.2246941262729311
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22953,1264,1.44 [1.33-1.56],3.999506983988864e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,21828,138,0.93 [0.69-1.26],0.6558779980917548
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21223,5124,1.18 [1.13-1.23],3.3942599953788494e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22073,383,1.03 [0.87-1.23],0.7035534789767228
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,21985,296,1.53 [1.31-1.78],5.4739840478926094e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Emphysema,20218,339,1.96 [1.71-2.25],5.126743869347614e-22
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22269,323,2.83 [2.47-3.24],8.055445078388657e-51
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22928,2081,1.33 [1.24-1.43],4.301145478896613e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22296,350,2.66 [2.33-3.04],1.1817109790062544e-46
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Later onset COPD,22142,968,1.41 [1.28-1.54],1.1709698688560228e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23153,415,1.20 [1.02-1.40],0.0252323738246085
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,21827,137,0.79 [0.58-1.07],0.1282608636085735
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22904,959,1.39 [1.25-1.53],1.8053433731682047e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22898,2121,1.32 [1.23-1.41],1.1620917418658742e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22533,843,0.93 [0.82-1.05],0.233665657039465
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other pleural conditions,20843,66,1.62 [1.12-2.35],0.0107938026483584
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23078,431,2.34 [2.06-2.65],2.9336586779063384e-39
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23051,1351,1.36 [1.25-1.48],1.0914946053235764e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,21854,1077,1.29 [1.17-1.42],2.0171307543583774e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural plaque,21032,255,1.45 [1.20-1.76],0.0001315424785994
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22670,1823,1.34 [1.25-1.44],2.9394088021119045e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23056,318,1.04 [0.86-1.25],0.7020288492995614
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumothorax,20916,139,1.44 [1.11-1.87],0.0054543782748235
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pollen allergy,23155,225,0.76 [0.59-0.97],0.0265746965010564
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22714,67,1.30 [0.89-1.89],0.1786363926121999
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15157,55,1.77 [1.20-2.61],0.004091136299602
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22889,944,1.39 [1.25-1.54],1.9212302532635187e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21949,259,0.76 [0.61-0.96],0.0211702770497554
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Viral pneumonia,21119,272,1.19 [0.98-1.46],0.0834852505810585
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22817,231,1.17 [0.94-1.45],0.1665893830907917
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10091,110,1.16 [0.84-1.59],0.3687612596587641
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16190,89,0.88 [0.61-1.26],0.4736457995768247
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,23044,140,0.92 [0.69-1.24],0.5874487276041218
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute gastritis,17502,89,0.87 [0.60-1.26],0.4643014916686827
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21871,186,1.02 [0.79-1.30],0.8884136808983162
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute peritonitis,22823,94,0.99 [0.70-1.41],0.9671616041140816
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22314,111,1.11 [0.84-1.48],0.4653512851873321
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,17923,510,1.09 [0.94-1.27],0.2644321092090003
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21803,118,1.17 [0.86-1.58],0.3086408638339503
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22778,118,1.16 [0.86-1.57],0.3245223071113048
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,21892,207,1.13 [0.90-1.43],0.2895241534500521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,22437,752,0.98 [0.86-1.11],0.7532140750277349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,17670,257,0.96 [0.77-1.20],0.7212477432052241
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21741,56,0.92 [0.60-1.42],0.7127641718733473
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22974,125,1.09 [0.81-1.46],0.5667296702521234
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,21584,91,1.29 [0.92-1.83],0.1436381576301854
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Collagenous colitis,21783,48,1.00 [0.62-1.62],0.9997308485086568
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23009,213,0.89 [0.70-1.13],0.3256176191916141
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,23015,1546,1.05 [0.96-1.14],0.308342682559337
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,21823,88,1.05 [0.73-1.50],0.8018702434158175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22837,62,1.05 [0.69-1.60],0.8306348581818284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21810,75,1.02 [0.69-1.50],0.928047240085303
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,22548,217,0.98 [0.78-1.22],0.8362184351780202
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19649,1889,1.07 [0.99-1.16],0.0727352673980493
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,23072,168,0.94 [0.72-1.23],0.6628640788320956
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,23036,833,1.06 [0.95-1.19],0.2899472277201589
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21225,3812,1.09 [1.04-1.16],0.0013026519500442
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22821,490,1.01 [0.87-1.17],0.8907644742841111
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23123,394,1.03 [0.86-1.22],0.7535939839735258
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22436,105,0.92 [0.66-1.28],0.6030791278295251
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22299,65,1.20 [0.80-1.80],0.3654302353371984
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22867,1374,1.16 [1.06-1.26],0.001143341891388
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of tongue,22320,105,1.21 [0.88-1.67],0.2355952199719172
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22812,1127,1.03 [0.94-1.14],0.5030229719320943
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19059,2958,1.02 [0.95-1.08],0.6065008722640908
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17675,262,1.26 [1.03-1.54],0.0219609591072329
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23060,205,1.15 [0.92-1.44],0.219856068623152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23097,46,0.77 [0.45-1.32],0.3431878364469718
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22349,146,1.06 [0.81-1.39],0.6736289073926092
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16277,176,0.93 [0.72-1.21],0.5995522713228977
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,17828,415,1.05 [0.89-1.25],0.5391469426637827
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,17767,354,1.15 [0.96-1.36],0.123292369324892
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19493,2080,1.07 [0.99-1.15],0.082334030770971
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17994,581,1.16 [1.01-1.33],0.0330719622269009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17728,7750,1.01 [0.97-1.05],0.5006935470522442
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,22631,1138,1.17 [1.06-1.29],0.001352840434056
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22373,42,0.53 [0.30-0.95],0.0336492239769455
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17038,1200,0.99 [0.89-1.09],0.8219385274035573
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22283,80,1.26 [0.90-1.77],0.1846523458378028
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,21185,3425,1.00 [0.94-1.06],0.8692977622589501
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,23100,43,0.80 [0.46-1.39],0.4246567609455938
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impaction of intestines,16148,47,1.18 [0.74-1.89],0.4914791723116061
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,19342,1582,0.92 [0.84-1.00],0.0575805905367234
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17952,192,1.03 [0.80-1.33],0.8121813358943106
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16189,88,0.74 [0.50-1.08],0.116547909273899
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21597,104,1.32 [0.95-1.82],0.0952652169737353
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16367,266,0.99 [0.80-1.22],0.9188285620927138
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23128,365,1.01 [0.85-1.21],0.8933948724873231
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22392,657,1.09 [0.95-1.24],0.2049674697054797
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22591,856,1.07 [0.96-1.21],0.2187998703926903
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17620,207,1.05 [0.83-1.33],0.6795288621102158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,18016,603,1.13 [0.99-1.30],0.0768606288798092
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23119,111,1.03 [0.75-1.41],0.85532436956796
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17833,73,1.33 [0.90-1.95],0.1539701331531579
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17491,1390,1.05 [0.95-1.15],0.3365908519443696
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21937,252,0.96 [0.78-1.19],0.7174449819789284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21797,112,0.92 [0.67-1.28],0.6398493906879881
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,17925,1824,1.06 [0.98-1.15],0.139470217005933
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21411,5310,1.02 [0.97-1.06],0.5329206311205047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22282,174,1.01 [0.78-1.30],0.9677274899266152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,22866,663,1.12 [0.99-1.27],0.0818641491692196
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18126,713,1.20 [1.05-1.35],0.0051127000671782
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21819,134,1.27 [0.97-1.67],0.0877006708164531
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23054,325,1.04 [0.86-1.26],0.6893021208600665
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18189,776,1.14 [1.01-1.29],0.034016216625532
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22643,1150,1.17 [1.06-1.29],0.0013122234914316
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22496,165,1.22 [0.96-1.57],0.1084091319222919
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17682,1581,1.05 [0.97-1.14],0.2492944463509993
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19232,1819,1.15 [1.06-1.24],0.0004565185448857
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22295,92,0.88 [0.61-1.27],0.4975946902560245
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22487,752,1.06 [0.94-1.20],0.348963620914314
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16441,340,1.12 [0.94-1.34],0.2036922283008923
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23089,55,0.76 [0.46-1.25],0.2780086776195669
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16566,465,1.06 [0.91-1.23],0.4861653718440367
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21653,160,0.94 [0.72-1.23],0.6615698796223256
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23157,42,0.80 [0.46-1.41],0.4431697774397107
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22339,99,0.86 [0.60-1.23],0.4028681808312571
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Toxic colitis,21777,42,0.99 [0.58-1.67],0.959846740108368
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17696,283,1.08 [0.88-1.31],0.4786199210492009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21878,143,0.98 [0.74-1.32],0.915513720086462
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21855,120,0.92 [0.66-1.26],0.5883156702135264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,18115,355,0.99 [0.82-1.19],0.9175298091893244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16254,153,1.37 [1.06-1.76],0.0144898710711412
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,18011,251,1.15 [0.93-1.41],0.2021244247617998
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Volvulus,16175,74,1.00 [0.67-1.49],0.9982648860632192
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23097,318,0.84 [0.68-1.02],0.0851887904689777
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22860,65,1.20 [0.78-1.83],0.4029584877636444
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21223,92,1.19 [0.84-1.69],0.3346738957861809
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22443,727,1.07 [0.94-1.21],0.3009693493071844
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21913,197,0.92 [0.73-1.18],0.5211198409326767
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21592,461,1.16 [1.00-1.35],0.0469648429273654
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22882,261,1.13 [0.92-1.39],0.2576204431433034
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23082,461,1.04 [0.89-1.22],0.5974243609727521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22664,43,0.94 [0.55-1.63],0.8363181024932943
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21719,3097,1.03 [0.97-1.09],0.3577156230755959
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22734,398,1.02 [0.86-1.21],0.8342469312485512
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22624,288,0.99 [0.81-1.21],0.9301513045677194
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22713,997,1.03 [0.93-1.15],0.572362294897416
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23161,30,0.94 [0.49-1.79],0.8514666357149168
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21154,23,1.33 [0.69-2.56],0.3875534315910526
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22392,56,1.08 [0.69-1.70],0.7322387246779041
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22878,257,1.13 [0.92-1.40],0.2393639413366087
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21602,471,1.14 [0.97-1.33],0.103906335712024
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21208,77,1.08 [0.73-1.58],0.7074906600804214
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23103,83,1.30 [0.92-1.84],0.1395038121990944
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21930,214,1.00 [0.79-1.27],0.9868271641629996
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23006,211,1.18 [0.94-1.48],0.1541292572924147
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22691,70,1.01 [0.68-1.50],0.9572054771673848
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21196,65,0.75 [0.47-1.19],0.2167929202281048
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22727,1596,1.05 [0.96-1.14],0.2835883564555309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21639,508,1.14 [0.98-1.32],0.0946428752899702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21211,80,1.04 [0.71-1.52],0.8333713723418079
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23085,290,1.18 [0.97-1.44],0.0909152064991482
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22672,51,1.00 [0.63-1.59],0.9934586289489252
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23049,254,1.22 [1.00-1.50],0.0555038061452199
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23116,337,0.85 [0.70-1.03],0.0951687213074997
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21216,85,1.21 [0.84-1.74],0.3051375609421842
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21397,266,0.87 [0.70-1.08],0.2158230223847478
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23109,330,0.85 [0.69-1.03],0.0979642275834026
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21393,262,1.10 [0.90-1.34],0.3423887652636815
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23144,124,1.04 [0.77-1.40],0.7926206672266286
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19983,84,0.99 [0.68-1.45],0.9743517737448923
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21137,4637,1.02 [0.97-1.07],0.4219799847258394
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19770,3270,1.03 [0.97-1.09],0.4041623761203898
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19968,69,0.83 [0.54-1.27],0.3838997117716577
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20343,145,1.06 [0.81-1.40],0.6613854288324433
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20340,142,1.28 [0.97-1.67],0.0769471316663742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22970,67,0.94 [0.62-1.42],0.7670230450369073
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20277,79,1.11 [0.78-1.59],0.564673692891049
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17347,847,1.10 [0.98-1.24],0.1129855248066796
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23056,147,1.15 [0.88-1.52],0.3088366330618742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20462,264,1.15 [0.93-1.41],0.1884529203000814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19712,6085,1.03 [0.99-1.08],0.1388480403135475
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22136,88,0.93 [0.65-1.34],0.7100273780151256
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20062,163,1.02 [0.79-1.33],0.8637330507279757
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20324,425,1.02 [0.86-1.21],0.8006162980271846
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22377,2179,1.02 [0.95-1.10],0.5274507568741867
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20257,358,1.13 [0.94-1.35],0.1908505049472979
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19951,52,1.25 [0.80-1.95],0.3326727687149688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19993,94,0.82 [0.56-1.20],0.3106349882400748
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22858,28,0.77 [0.40-1.50],0.4482404771848299
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17919,1419,0.97 [0.88-1.07],0.5237383034580554
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17446,946,1.07 [0.96-1.20],0.2181630984024312
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23038,933,1.06 [0.95-1.18],0.3158017970450033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16546,46,0.82 [0.47-1.41],0.4653712981859541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16579,79,0.70 [0.46-1.07],0.1028865467917827
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20159,260,0.96 [0.77-1.19],0.6870625797106118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17108,608,1.03 [0.89-1.19],0.6800740925841661
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20238,40,1.11 [0.67-1.87],0.6804834506263494
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20722,524,1.11 [0.96-1.29],0.15586964031425
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20460,262,0.92 [0.75-1.15],0.4763826984696153
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17071,571,1.04 [0.89-1.20],0.6281906792471483
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19963,64,1.05 [0.69-1.61],0.8122606017664591
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19952,53,1.30 [0.84-2.02],0.2403114055113412
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22137,89,1.00 [0.70-1.43],0.9887632772647716
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22887,839,1.10 [0.98-1.23],0.117711636654837
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22433,385,1.14 [0.97-1.35],0.1149226545832824
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23088,274,1.12 [0.92-1.36],0.2657753975994616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18331,1831,1.08 [1.00-1.17],0.0637405040741336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16551,51,1.18 [0.72-1.94],0.5053808995589955
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19980,81,1.22 [0.84-1.75],0.2953540807108771
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16552,52,1.17 [0.72-1.89],0.5232427728876795
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16546,46,0.87 [0.51-1.49],0.6165073908373121
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22232,184,1.14 [0.89-1.45],0.2967359594925988
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22206,158,1.31 [1.01-1.70],0.0414570875119548
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23135,85,1.50 [1.08-2.10],0.0157627332418042
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21691,1493,1.01 [0.93-1.11],0.742239049097903
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19960,61,1.16 [0.75-1.79],0.5152823221175898
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16540,40,0.70 [0.38-1.28],0.2428789305494534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20797,599,1.00 [0.87-1.15],0.9641854862093494
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18162,1662,1.04 [0.95-1.13],0.4119136329796435
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22881,51,1.09 [0.69-1.71],0.7160937152771367
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23152,59,1.25 [0.81-1.94],0.3088148560648862
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19977,78,0.90 [0.61-1.33],0.6079281456922898
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20867,968,1.09 [0.98-1.22],0.1184000703318952
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19991,92,0.99 [0.69-1.41],0.9404313025298374
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17672,1172,1.10 [0.99-1.21],0.0719643212259072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22133,85,1.05 [0.73-1.51],0.792539407355553
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19940,41,0.85 [0.48-1.53],0.5900214186048856
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20309,111,1.26 [0.93-1.72],0.1349560729837485
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20396,497,1.05 [0.90-1.23],0.5038973289359945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23021,191,1.08 [0.84-1.38],0.5676837161554349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20672,474,1.15 [0.99-1.34],0.0751143608556878
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23097,269,1.15 [0.94-1.40],0.1687460663118447
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23155,38,1.49 [0.91-2.46],0.1137267962280943
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20044,145,1.09 [0.83-1.45],0.5299918686705989
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19001,562,1.11 [0.96-1.28],0.1470107789148283
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20371,472,1.06 [0.91-1.24],0.4601509386180051
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20225,326,1.14 [0.95-1.37],0.1682438236862573
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16530,30,1.08 [0.57-2.03],0.8166714738030565
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18697,2197,1.09 [1.01-1.17],0.0256621171764071
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16937,437,1.07 [0.91-1.26],0.425736123794222
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22993,163,1.07 [0.82-1.40],0.612956737460072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23096,46,1.67 [1.08-2.60],0.0223404645549881
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21240,46,1.11 [0.68-1.80],0.689820110770539
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16561,61,1.29 [0.83-2.00],0.2495534160017716
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20286,88,1.50 [1.07-2.09],0.017507645951286
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16782,282,1.16 [0.95-1.41],0.1489663197828132
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20168,269,1.09 [0.89-1.34],0.4143830104255737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20408,210,0.79 [0.62-1.01],0.0646896396174007
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20291,93,1.18 [0.83-1.66],0.3544506017905808
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18402,30,0.59 [0.30-1.14],0.1178072380278397
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23156,39,1.45 [0.89-2.37],0.1365739027246833
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20410,511,1.05 [0.90-1.22],0.5137638001216265
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22848,18,0.94 [0.41-2.15],0.8828581170245793
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22119,2220,1.07 [1.00-1.15],0.06074405164703
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20000,101,0.94 [0.66-1.33],0.7190680038983679
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20691,493,0.99 [0.84-1.15],0.8657764616228576
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22143,190,1.17 [0.92-1.49],0.1985250710641969
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20322,124,1.22 [0.91-1.64],0.1849303578118499
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21478,1280,1.08 [0.98-1.18],0.1207891186915976
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21000,802,1.13 [1.01-1.27],0.0389132904037077
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19940,41,1.48 [0.90-2.45],0.1227948581114447
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22868,38,1.36 [0.82-2.24],0.2288571886086093
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20016,117,1.23 [0.91-1.67],0.1743586432485597
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19920,21,1.37 [0.70-2.66],0.3570435571632601
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16560,60,1.37 [0.91-2.06],0.1325532771753286
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22198,1818,1.22 [1.13-1.31],2.8086302379739485e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22711,387,1.04 [0.87-1.23],0.6780974149095127
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22458,134,1.09 [0.81-1.46],0.5695161632320958
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21875,1495,1.22 [1.12-1.33],4.328540337447044e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22922,82,1.38 [0.98-1.95],0.0614160256475904
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22896,345,1.17 [0.98-1.40],0.0842203171903778
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,20375,205,1.00 [0.79-1.27],0.988000101656582
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dialysis,20482,102,1.56 [1.15-2.11],0.0040243345219971
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,21916,3238,1.04 [0.98-1.11],0.1951046868393883
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20858,5434,1.09 [1.04-1.14],0.0002058350351745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22941,101,1.29 [0.94-1.77],0.1130844604333303
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,18876,198,1.14 [0.89-1.45],0.2978160566695601
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20479,357,1.00 [0.83-1.20],0.9749313360662298
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21216,2538,1.05 [0.98-1.13],0.14164471945106
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18909,231,1.01 [0.80-1.27],0.9284415148615552
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20243,73,1.33 [0.92-1.91],0.1284601310295497
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18788,110,1.32 [0.98-1.79],0.0698476005261383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23159,58,0.91 [0.58-1.42],0.6619689314082842
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23164,54,1.26 [0.82-1.94],0.2859393996900476
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22368,2198,1.13 [1.05-1.22],0.0006084886854511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21094,924,1.13 [1.02-1.27],0.0252963476382963
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23097,546,1.22 [1.06-1.40],0.0052585175382852
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18984,306,1.27 [1.05-1.53],0.0124188080078113
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18957,279,1.01 [0.82-1.24],0.9361063031238076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,18899,221,0.75 [0.59-0.96],0.0225051158860774
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23153,46,1.32 [0.83-2.10],0.2368315398679104
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21670,1500,1.13 [1.04-1.23],0.0041053755870093
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20520,398,1.03 [0.87-1.22],0.7343126910485615
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22737,186,1.24 [0.98-1.57],0.0758771020264277
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22898,58,0.92 [0.58-1.46],0.7317434708190826
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18940,262,0.88 [0.71-1.10],0.2639595779276541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22869,2747,1.17 [1.10-1.25],8.349936104955546e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20192,70,0.87 [0.57-1.33],0.5183203506670453
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20531,151,1.21 [0.94-1.57],0.1384418256480231
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22397,73,0.80 [0.53-1.21],0.280670998811565
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20458,288,1.12 [0.92-1.36],0.2690669402465956
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22823,499,1.02 [0.87-1.19],0.8118665645118676
